U.S. Stock News

Ever wondered whether Huron Consulting Group is a bargain or priced for perfection? If you are curious about where the stock stands on value right now, you are not alone. Recently, the stock has been anything but quiet, climbing 8.2% this past week, 9.7% over the last month, and delivering a remarkable 33.7% gain year-to-date. These sharp moves have been drawing attention, especially following Huron’s recent announcement of a new strategic partnership and industry accolade. Both of these...

Hamilton Lane (HLNE) delivered a net profit margin of 31.1%, up from last year’s 28%, reflecting high quality earnings. Over the past year, earnings growth reached 25.5%, outpacing the company’s 5-year annual average of 16.7%. Looking ahead, revenue is forecast to grow by 14.6% per year, topping the US market average of 10.5%. The business is trading at a premium with a price-to-earnings ratio of 23.5x compared to peer averages. Investors may see these strong margins and solid growth rates as...

Wondering if Qualys is really worth its current price tag? You are not alone. It pays to dig into what drives the stock’s value before making any decisions. The stock has had a choppy ride lately, down 4.6% over the past week and dropping 12.7% so far this year. This has changed the mood on growth potential and risk. Recent headlines around Qualys have focused on the company's evolving cybersecurity offerings and new partnerships with industry leaders. These developments have attracted...

Thinking about whether AES is a good buy? You're not alone. If you're searching for value, there are some surprising signals just beneath the surface. AES stock has had a turbulent ride, slipping 7.1% over the past week and 7.8% in the last month. However, it's still managed a 3.0% gain year-to-date. Recent headlines have focused on changes in the renewable energy landscape and evolving regulatory support, both of which have added fuel to speculation around utility stocks. Developments in...

Xenon Pharmaceuticals (XENE) reported continued unprofitability in its latest quarter and is projected to remain in the red for at least three more years. Over the past five years, losses have grown at an average yearly rate of 37%. However, revenue growth is forecast to accelerate at 72.4% per year, outpacing both the broader US market and the biotech sector. Despite substantial top-line momentum, margins and net profit have yet to improve, keeping earnings quality under pressure. See our...

Greenfire Resources (NYSE:GFR) just posted a dramatic turnaround, with earnings growth reversing from a 20.2% annual decline over the past five years to a staggering 252.7% increase last year. The company’s net profit margin jumped to 19.1% from 5.1% a year ago, while shares now trade at just 3.3x earnings, which is far below the industry average of 12.8x and the peer average of 19.2x. This comes despite a current share price of $4.47 compared to a fair value estimate of $186.11. Momentum has...

Hims & Hers Health (HIMS) posted strong revenue and earnings growth forecasts, with revenue expected to rise 14.7% per year and earnings projected to climb 27.5% annually. Both figures surpass broader US market trends. While the company’s average annual earnings growth reached 62.2% over the past five years, the most recent year saw a 32.1% expansion, and net profit margins dipped to 6.1% compared to 8.2% a year ago. Investors are weighing a solid profitability record and bright growth...

SBA Communications (SBAC) posted net profit margins of 30.7%, rising from 25.8% the previous year, with annual earnings growth averaging 34.2% over the last five years. More recent earnings growth for the past year came in at 25%. Revenue is forecast to grow at just 3% annually, and earnings are expected to increase by 2% per year. Both of these figures trail the broader US market benchmarks. With a Price-To-Earnings ratio of 24.4x, below both its peer average of 30.5x and the industry...

Curious if Four Corners Property Trust is a bargain or too pricey in today’s market? Let’s break down what’s driving the stock’s value and whether there’s opportunity ahead. Even though the stock slipped 0.1% over the past week and 1.8% in the last 30 days, it is only down 9.8% in the past year, showing signs of resilience amidst a tough environment. Investors have been keeping an eye on rising interest rates and evolving commercial real estate trends, both of which continue to influence...

Inspire Medical Systems (INSP) reported net profit margins of 5%, up from 4.4% the previous year, signaling improved profitability. The company has transitioned to steady profits over the past five years, averaging 56.3% annual earnings growth. However, the most recent year saw earnings rise by 34.8%. Forecasts call for 25.6% annual EPS growth and revenue expansion of 10.7% per year, both outpacing the US market. Investors are likely weighing robust future prospects against a premium...

If you have ever wondered whether Vertex stock is trading at a bargain or an inflated price, you are in the right place for some answers. After a rough few months, Vertex shares have dropped by 20.7% over the last week and are down 54.4% over the past year, suggesting a dramatic shift in market sentiment around the company. Much of this decline has been set against a backdrop of challenging headlines, including industry-wide volatility in the software sector, as well as broader market...

CVR Partners (NYSE:UAN) just released third quarter results that showed a sharp rise in both earnings and cash distribution compared to last year, giving investors plenty to talk about this week. See our latest analysis for CVR Partners. After such a jump in earnings and another bump to its distribution, it’s no surprise investors have taken notice. CVR Partners’ share price is up 27.3% year-to-date, while the one-year total shareholder return stands at an impressive 63.3%. Momentum has built...

Wondering if Fastly could be a hidden gem or just another risky play? Let’s break down what’s driving interest in the stock right now and whether its current price tells the full story. Fastly’s share price has been bouncing around recently, with a -4.0% move in the last week and down nearly 10% over the past month. However, it is still sitting about 3.8% higher than a year ago. Recent headlines highlight Fastly’s rollout of new edge cloud technologies and ongoing partnerships with major...

Ever wondered if Insulet is actually worth its current share price? You are not alone in wanting to know whether this fast-growing company could offer real value, or if the opportunity has already passed by. Insulet's stock has climbed 24.7% year-to-date and an impressive 32.7% over the last year, but it has pulled back a modest 1.3% in the past week, hinting at some recent volatility. News around advancements in Insulet’s Omnipod technology and expanding market access has continued to...

In October 2025, Visteon Corporation reported third-quarter earnings, with net income increasing to US$57 million despite lower sales, and announced its first quarterly dividend alongside plans for technology-focused acquisitions supported by a net cash position of US$459 million. This combination of higher earnings, a new dividend, and acquisition ambitions underscores Visteon's focus on balanced capital allocation and future technological growth. We'll explore how Visteon's initiation of a...

Corebridge Financial (CRBG) has turned the corner to profitability over the last year, with forecasts now calling for earnings growth of 51.05% per year. That is more than triple the broader US market average of 16%. Revenue is set to grow at a slower pace of 7.6% per year, which trails the US market’s 10.5% growth. Margins have also rebounded as the company moved from losses into positive territory, drawing attention as a potential turnaround story this earnings season. See our full analysis...

Premier (PINC) reported a net profit margin of just 0.7% this quarter, a sharp drop from last year’s 11.2%, with earnings having declined at an average annual rate of -25.5% over the past five years. Despite recent pressures, the company is now profitable and is forecasting a robust 32.6% annual earnings growth over the next three years, which is double the 16% expected for the US market overall. These mixed results, combined with a one-off $162.9 million loss, have pushed Premier’s shares to...

PJT Partners (PJT) posted a net profit margin of 10.7%, up from 8% last year, signaling improved profitability. Earnings are on a tear, with annual growth hitting 64.9%, far exceeding the firm’s 5-year average of 6.4% per year and pointing to a period of rapid acceleration. Despite this robust earnings momentum, analysts expect future earnings to contract by 2.8% per year while revenue growth is forecast at 8.6%, trailing the broader US market’s 10.5% pace. This may lead investors to...

Kura Oncology (KURA) remains unprofitable and is projected to stay in the red for at least the next three years, with losses having widened at a pace of 15.3% per year over the last five. Despite negative profit margins and no signs of bottom-line improvement, the company is forecast to deliver revenue growth of 42.7% annually, significantly outpacing the broader US market’s 10.5% revenue growth expectation. Investors now face a trade-off between robust top-line growth potential and the...

ONE Gas (OGS) reported net profit margins of 10.8%, slightly ahead of last year’s 10.5%, as annual earnings growth reached 17.7%, substantially outpacing the company’s five-year average of 4.5%. Earnings are forecast to grow at 8.94% per year, but both profit and revenue trends remain below broader US market averages. Investors will note that despite stronger bottom-line results, valuation appears mixed given that the stock’s Price-to-Earnings ratio sits between its US and global gas utility...

Wondering if ONEOK might be a hidden value in the energy sector? Let’s dig into whether the numbers back up that gut feeling, especially if you are looking for opportunities others might have missed. The stock has had a rough patch recently, sliding 6.9% over the past week and 11.8% over the last month, with a year-to-date drop of 36.8% and a one-year loss of 31.4%. Looking at a longer timeline, over five years shares are still up an impressive 164.5%. Some of the recent price movement...

Harmony Biosciences Holdings (HRMY) delivered a net profit margin of 22.5% this period, well above last year's 18%. Earnings grew by 51.4% over the past year, outpacing both its own five-year average growth rate of 40.8% and broader US market expectations. Looking ahead, analysts forecast earnings to grow 20.5% per year, surpassing the US market's 16%, while revenue is expected to rise at 12.7% annually compared to the market's 10.5% pace. This combination of sustained profitability and...

On November 3, 2025, Prelude Therapeutics announced a private placement, raising US$25,000,000 by issuing 6,250,000 shares at US$4 each, with participation from Incyte Corporation. Institutional interest from a company like Incyte can be viewed as an endorsement of Prelude’s research direction and funding outlook. We’ll explore how Incyte’s involvement in the private placement shapes Prelude’s investment narrative and financial flexibility. The best AI stocks today may lie beyond giants like...

Expeditors International of Washington (EXPD) reported a net profit margin of 7.6%, up from 7.4% a year ago, signaling a modest expansion in profitability. Earnings grew 15.4% over the past year. However, the longer-term five-year trend shows a decline of 6% per year. Looking ahead, analysts expect earnings to decline by 1.1% annually over the next three years, along with minimal revenue growth of 0.2% per year. This trails well behind the broader US market's projected 10.5% annual rate. The...